TMO Thermo Fisher Scientific Inc

Price (delayed)

$518.22

Market cap

$205.39B

P/E Ratio

42.13

Dividend/share

$0.88

EPS

$12.3

Enterprise value

$218.94B

Sector: Healthcare
Industry: Diagnostics & Research

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry . ...

Highlights

Thermo Fisher Scientific's quick ratio has soared by 110% YoY and by 19% from the previous quarter
TMO's EPS is up by 37% year-on-year and by 32% since the previous quarter
The stock's price to earnings (P/E) is 30% more than its 5-year quarterly average of 32.5 and 23% more than its last 4 quarters average of 34.3
The debt has increased by 24% YoY

Key stats

What are the main financial stats of TMO
Market
Shares outstanding
396.34M
Market cap
$205.39B
Enterprise value
$218.94B
Valuations
Price to earnings (P/E)
42.13
Price to book (P/B)
6.44
Price to sales (P/S)
7.2
EV/EBIT
33.92
EV/EBITDA
25.01
EV/Sales
7.68
Earnings
Revenue
$28.5B
EBIT
$6.45B
EBITDA
$8.75B
Free cash flow
$5.71B
Per share
EPS
$12.3
Free cash flow per share
$14.42
Book value per share
$80.45
Revenue per share
$71.96
TBVPS
$64.16
Balance sheet
Total assets
$64.06B
Total liabilities
$32.24B
Debt
$21.09B
Equity
$31.82B
Working capital
$12.01B
Liquidity
Debt to equity
0.66
Current ratio
2.93
Quick ratio
2.04
Net debt/EBITDA
1.55
Margins
EBITDA margin
30.7%
Gross margin
47.3%
Net margin
17.1%
Operating margin
20.9%
Efficiency
Return on assets
8%
Return on equity
16.3%
Return on invested capital
20.9%
Return on capital employed
11.2%
Return on sales
22.6%
Dividend
Dividend yield
0.17%
DPS
$0.88
Payout ratio
7.2%

TMO stock price

How has the Thermo Fisher Scientific stock price performed over time
Intraday
0.46%
1 week
4.29%
1 month
11.96%
1 year
53.66%
YTD
11.26%
QTD
11.26%

Financial performance

How have Thermo Fisher Scientific's revenue and profit performed over time
Revenue
$28.5B
Gross profit
$13.48B
Operating income
$5.96B
Net income
$4.88B
Gross margin
47.3%
Net margin
17.1%
Thermo Fisher Scientific's net income has increased by 36% YoY and by 32% from the previous quarter
The operating income has grown by 33% from the previous quarter and by 32% YoY
Thermo Fisher Scientific's operating margin has increased by 23% from the previous quarter and by 17% YoY
The net margin has increased by 21% QoQ and by 20% YoY

Growth

What is Thermo Fisher Scientific's growth rate over time

Valuation

What is Thermo Fisher Scientific stock price valuation
P/E
42.13
P/B
6.44
P/S
7.2
EV/EBIT
33.92
EV/EBITDA
25.01
EV/Sales
7.68
TMO's EPS is up by 37% year-on-year and by 32% since the previous quarter
The stock's price to earnings (P/E) is 30% more than its 5-year quarterly average of 32.5 and 23% more than its last 4 quarters average of 34.3
The P/B is 84% above the 5-year quarterly average of 3.5 and 43% above the last 4 quarters average of 4.5
The company's equity rose by 8% YoY and by 7% QoQ
The P/S is 80% above the 5-year quarterly average of 4.0 and 41% above the last 4 quarters average of 5.1
Thermo Fisher Scientific's revenue has increased by 13% YoY and by 9% from the previous quarter

Efficiency

How efficient is Thermo Fisher Scientific business performance
The ROE has grown by 29% from the previous quarter and by 28% YoY
TMO's ROA is up by 27% from the previous quarter and by 27% YoY
TMO's return on invested capital is up by 22% since the previous quarter and by 7% year-on-year
TMO's ROS is up by 18% since the previous quarter and by 9% year-on-year

Dividends

What is TMO's dividend history
DPS
$0.88
Dividend yield
0.17%
Payout ratio
7.2%
Recent dividends

Financial health

How did Thermo Fisher Scientific financials performed over time
The total assets is 99% greater than the total liabilities
Thermo Fisher Scientific's quick ratio has soared by 110% YoY and by 19% from the previous quarter
The current ratio has surged by 63% year-on-year and by 12% since the previous quarter
The debt is 34% lower than the equity
Thermo Fisher Scientific's debt to equity has increased by 14% YoY but it has decreased by 7% QoQ
The company's equity rose by 8% YoY and by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.